BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9484308)

  • 1. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
    Skodol AE; Oldham JM; Gallaher PE
    Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisocial personality disorder among drug abusers. Relations to other personality diagnoses and the five-factor model of personality.
    Brooner RK; Herbst JH; Schmidt CW; Bigelow GE; Costa PT
    J Nerv Ment Dis; 1993 May; 181(5):313-9. PubMed ID: 8501448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use disorders in a sample of Canadian patients with chronic mental illness.
    Toner BB; Gillies LA; Prendergast P; Cote FH; Browne C
    Hosp Community Psychiatry; 1992 Mar; 43(3):251-4. PubMed ID: 1555819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of personality disorders in substance abusers: a comparison between DSM-III-R and DSM-IV.
    Poling J; Rounsaville BJ; Ball S; Tennen H; Kranzler HR; Triffleman E
    J Pers Disord; 1999; 13(4):375-84. PubMed ID: 10633317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comorbidity of borderline personality disorder and other DSM-III-R axis II personality disorders.
    Nurnberg HG; Raskin M; Levine PE; Pollack S; Siegel O; Prince R
    Am J Psychiatry; 1991 Oct; 148(10):1371-7. PubMed ID: 1897619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of axis I and axis II disorders.
    Oldham JM; Skodol AE; Kellman HD; Hyler SE; Doidge N; Rosnick L; Gallaher PE
    Am J Psychiatry; 1995 Apr; 152(4):571-8. PubMed ID: 7694906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSM-IV axis II comorbidity with borderline personality disorder in monolingual Hispanic psychiatric outpatients.
    Grilo CM; Miguel Anez L; McGlashan TH
    J Nerv Ment Dis; 2002 May; 190(5):324-30. PubMed ID: 12011613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axis II comorbidity in substance abusers.
    Nace EP; Davis CW; Gaspari JP
    Am J Psychiatry; 1991 Jan; 148(1):118-20. PubMed ID: 1984695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.
    Cecero JJ; Ball SA; Tennen H; Kranzler HR; Rounsaville BJ
    J Nerv Ment Dis; 1999 Aug; 187(8):478-86. PubMed ID: 10463065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome.
    Ross S; Dermatis H; Levounis P; Galanter M
    Am J Drug Alcohol Abuse; 2003 May; 29(2):263-79. PubMed ID: 12765206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
    Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
    Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.